NCT05615012View on ClinicalTrials.gov

A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

December 13, 2023

Study Completion Date

December 13, 2023

Conditions
Healthy Participants
Interventions
DRUG

BMS-986322

Specified dose on specified days

DRUG

Rosuvastatin

Specified dose on specified days

DRUG

Metformin

Specified dose on specified days

DIETARY_SUPPLEMENT

Glucose

Specified dose on specified days

DRUG

Methotrexate

Specified dose on specified days

DRUG

Leucovorin

Specified dose on specified days

Trial Locations (1)

33136

Local Institution - 0001, Miami

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY